Literature DB >> 16707971

Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis.

Steven J Steiner1, Kevin M Kernek, Joseph F Fitzgerald.   

Abstract

OBJECTIVES: Basal cell hyperplasia of the esophageal epithelium is a frequent finding in children with histological evidence of esophagitis. The aim of this study was to compare the severity of basal cell hyperplasia in gastroesophageal reflux vs eosinophilic esophagitis.
METHODS: A cohort of pediatric patients who underwent same-day endoscopy with esophageal biopsy and 24-hour esophageal pH monitoring was divided into groups based on endoscopic and pH monitoring findings. Basal cell hyperplasia was defined as normal (< or = 25% of esophageal epithelial height), mild (26%-50%), moderate (51%-75%) or severe (> 75%). The severity of basal cell hyperplasia in patients with abnormal pH monitoring studies, both with and without endoscopic abnormalities of the esophagus, was compared with the severity in patients with eosinophilic esophagitis.
RESULTS: Twenty-seven children with abnormal pH monitoring were identified. Of these 27 children, 11 had endoscopic findings consistent with reflux esophagitis. Thirty patients with eosinophilic esophagitis were identified. Patients with eosinophilic esophagitis had significantly increased severity (P < 0.001) of basal cell hyperplasia (87% severe, 3% moderate, 3% mild, 7%, normal) than patients with abnormal esophageal pH monitoring alone (11% severe, 4% moderate, 15% mild, 70% normal) or in combination with endoscopic abnormalities (18% severe, 9% moderate, 18% mild, 55% normal).
CONCLUSIONS: Basal cell hyperplasia is more severe in children with eosinophilic esophagitis than in those with reflux esophagitis. The finding of basal cell hyperplasia is a powerful clue into the underlying etiology of pediatric esophagitis and, along with epithelial eosinophil count, can be used as information to guide therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16707971     DOI: 10.1097/01.mpg.0000221906.06899.1b

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  19 in total

1.  Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999.

Authors:  Charles W DeBrosse; Margaret H Collins; Bridget K Buckmeier Butz; Casey L Allen; Eileen C King; Amal H Assa'ad; J Pablo Abonia; Philip E Putnam; Marc E Rothenberg; James P Franciosi
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

Review 2.  Biology and treatment of eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

Review 3.  Roles and regulation of gastrointestinal eosinophils in immunity and disease.

Authors:  YunJae Jung; Marc E Rothenberg
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

Review 4.  Eosinophilic esophagitis: New insights in pathogenesis and therapy.

Authors:  Michele Pier Luca Guarino; Michele Cicala; Jose Behar
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

5.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

6.  Validation of methods to assess potential biomarkers in pediatric patients with esophageal eosinophilia.

Authors:  Jennifer M Colombo; Nancy A Neilan; Jennifer Verrill Schurman; Craig A Friesen
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-11-06

7.  Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis.

Authors:  Kathryn A Peterson; Kristen L Thomas; Kristen Hilden; Lyska L Emerson; Jason C Wills; John C Fang
Journal:  Dig Dis Sci       Date:  2009-06-18       Impact factor: 3.199

8.  A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study.

Authors:  Evan S Dellon; Spencer Rusin; Jessica H Gebhart; Shannon Covey; Olga Speck; Kimberly Woodward; Leana L Higgins; RoseMary Beitia; Ryan D Madanick; Sidney Levinson; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

9.  Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease.

Authors:  Evan S Dellon; Wood B Gibbs; Karen J Fritchie; Tara C Rubinas; Lindsay A Wilson; John T Woosley; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-03       Impact factor: 11.382

10.  FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.

Authors:  D J Mulder; I Pacheco; D J Hurlbut; N Mak; G T Furuta; R J MacLeod; C J Justinich
Journal:  Gut       Date:  2008-10-31       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.